Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland


Purpose:

The main purpose of this study is to examine the effect of dapagliflozin on electronic measures of heart beats in healthy males


Criteria:

Inclusion Criteria: - Healthy males age 18 to 45 years of age, who are not currently taking any medications - Normal screening results including a physical examination, laboratory tests, heart rate, blood pressure, and ECG (electronic measure of the heart) Exclusion Criteria: - No personal or family history of significant heart problems - No use of over the counter medications within 7 days of the study - No use of prescription medicaiton within 1 month of the study


NCT ID:

NCT00688493


Primary Contact:

Study Director
Glenn Carlson, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.